Esperion selects ESP-2001 as a preclinical candidate for primary sclerosing cholangitis, a rare liver disease, aiming to begin clinical studies in 2026.
Study shows Paris climate agreement has significantly reduced superhot days, but small nations face disproportionate impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results